...
首页> 外文期刊>Vaccine >Influenza vaccine effectiveness against medically-attended influenza illness during the 2012-2013 season in Beijing, China
【24h】

Influenza vaccine effectiveness against medically-attended influenza illness during the 2012-2013 season in Beijing, China

机译:在中国北京,2012-2013赛季流感疫苗对医疗照护流感的有效性

获取原文
获取原文并翻译 | 示例

摘要

Background: Influenza vaccine coverage remains low in China, and there is limited information on the preventive value of local vaccination programs. Methods: As part of influenza virological surveillance in Beijing, China during the 2012-2013 influenza season, we assessed the vaccine effectiveness (VE) of one or more doses of trivalent inactivated influenza vaccine (IIV3) in preventing medically-attended influenza-like-illness (ILI) associated with laboratory-confirmed influenza virus infection using a test-negative case-control design. Influenza vaccination was determined based on self-report by adult patients or the parents of child patients. Results: Of 1998 patients with ILI, 695 (35%) tested positive for influenza viruses, including 292 (42%) A(H3N2), 398 (57%) A(H1N1)pdm09, and 5 (1%) not (sub)typed influenza viruses. The rate of influenza vaccination among all patients was 4% (71/1998). Among influenza positive patients, 2% (57/1303) were vaccinated compared to 4% (14/695) among influenza negative patients, resulting in VE for one or more doses of vaccine (adjusted forage, sex, week, and days since illness onset) against all circulating influenza viruses of 52% (95% CI = 12-74%). A significant adjusted VE for one or more doses of vaccine for all ages against A(H1N1)pdm09 of 59% (95% Cl, 8-82%) was observed; however, the VE against A(H3N2) was 43% (95% CI, -30% to 75%). The point estimate of VE was 59% (95% CI, 19-79%) for those aged <60 years, but a negative VE point estimate without statistical significance was observed among those aged >= 60 years. Conclusions: IIV3 conferred moderate protection against medically-attended influenza in Beijing, China during the 2012-2013 season, especially against the A(H1N1)pdm09 strain and among those aged <60 years old
机译:背景:中国的流感疫苗覆盖率仍然很低,关于当地疫苗接种计划的预防价值的信息有限。方法:作为2012年至2013年流感季节在中国北京的流感病毒学监测的一部分,我们评估了一剂或多剂三价灭活流感疫苗(IIV3)在预防医学上类似流感的疫苗中的疫苗效力(VE)。使用测试阴性病例对照设计的实验室确诊流感病毒感染相关疾病(ILI)。流感疫苗接种是根据成人患者或儿童患者父母的自我报告确定的。结果:在1998年的ILI患者中,有695(35%)的流感病毒检测呈阳性,包括292(42%)A(H3N2),398(57%)A(H1N1)pdm09和5(1%)未检出(亚)型流感病毒。所有患者中的流感疫苗接种率为4%(71/1998)。在流感阳性的患者中,接种了2%(57/1303)的疫苗,而在流感阴性的患者中接种了4%(14/695),因此接种一剂或多剂疫苗后可产生VE(调整后的草料,性别,星期和天数)发病率)占所有循环流感病毒的52%(95%CI = 12-74%)。在所有年龄段,针对A(H1N1)pdm09的一剂或多剂疫苗,经调整的VE均达到59%(95%Cl,8-82%);但是,针对A(H3N2)的VE为43%(95%CI,-30%至75%)。 <60岁的人的VE点估计为59%(95%CI,19-79%),但在≥= 60岁的人中观察到阴性的VE点估计无统计学意义。结论:IIV3在2012-2013赛季期间为中国北京提供了针对医学感染型流感的中度保护,尤其是针对A(H1N1)pdm09菌株以及年龄小于60岁的人群

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号